Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Beijing Tongli Haiyuan Biotechnology

Request full access

Established a stable library of cell lines using GE Wave, GMP-grade production environment

ChinaFounded 2011Biotech & Life Sciences

About Beijing Tongli Haiyuan Biotechnology

T L Biotechnology is a pioneering company in the biotechnology sector, headquartered in Beijing, China, with a research center in Germany. The company specializes in the development and production of recombinant proteins, monoclonal antibodies, and sorting reagents, among other products. T L Biotechnology serves a diverse range of clients, including research institutions, pharmaceutical companies, and healthcare providers. Operating in the global biotechnology market, the company leverages its proprietary recombinant protein production platform and GMP-grade production environment to ensure high batch consistency and safety.

The business model of T L Biotechnology revolves around both product sales and customized services. The company generates revenue by selling its biotechnology products, such as recombinant proteins and sorting reagents, and by offering tailored solutions to meet specific client needs. This includes large-scale production capacities ranging from 5L to 500L and one-stop protein customization services.

T L Biotechnology's competitive advantage lies in its more than 10 years of experience in recombinant protein research, high success rate of expression, and convenient separation operations. The company is committed to maintaining high purity and bioactivity in its products, ensuring they meet the stringent requirements of its clients.

Source: Dealroom company data

At a glance

Status
Operational
Employees
11
Open positions
None listed
Dealroom signal
66.1/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, proteomics, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Jun 2025 $0 — Undisclosed ↗
SERIES A✓Equity / VC Mar 2023 $14M $55M Harvest Capital · Fortune Venture · Zhiheng (Yantai) ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Beijing Tongli Haiyuan Biotechnology website traffic

Latest recorded traffic for Beijing Tongli Haiyuan Biotechnology is 270 monthly website visits. Beijing Tongli Haiyuan Biotechnology's team declined 8.3% over the past year.

Latest monthly visits270 1-year team growth-8.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Beijing Tongli Haiyuan Biotechnology in its local ecosystem

Live from Dealroom

The Beijing Tongli Haiyuan Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Harvest Capital
  • Fortune Venture
  • Zhiheng (Yantai)
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇨🇳 China62.5%
🇺🇸 United States12.5%
🇩🇪 Germany12.5%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Beijing Tongli Haiyuan Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Beijing Tongli Haiyuan Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.